# Daily Iteration Run — 2026-06-28 (Sunday)

## State at start
- Papers: 285 total — 272 VETTED, 13 FLAGGED, **0 unvetted** (vetting backlog clear)
- Paths: 57 (37 VALIDATED, 17 PARTIALLY, 2 CONTRADICTED, 1 conditional)
- Gaps: 15 | Run history: 74 prior runs (this is run 75)
- No Monday weekly PubMed sweep (today is Sunday)

## Work completed (4 queue items)

### Path re-validation (2 stale PARTIALLY_VALIDATED paths)
1. **metformin -> nephropathy** — REAFFIRMED PARTIALLY_VALIDATED. New confirming evidence: 2026 SR/MA on metformin safety in CKD+T2D (Eur J Pharmacol, ScienceDirect S0014299926000427; searched to Sep 2025) + nationwide Scottish target-trial-emulation (stopping vs continuing metformin in advanced CKD). Signal supports renal safety/benefit, but still NO RCT with nephropathy/CKD as primary endpoint (unlike SGLT2i). Tier unchanged.
2. **belatacept -> T1D** — REAFFIRMED PARTIALLY_VALIDATED. No belatacept-specific T1D RCT beyond CIT-04/08; most recent durable-outcome pub remains 2023 (Transpl Int, doi:10.3389/ti.2023.11367 — 60-70% insulin-independent at 10-13y, one operationally tolerant off all IS). Sibling path belatacept -> islet_transplant stays VALIDATED.

### Gap audits (2 GOLD gaps, early — both due ~2026-07-02)
3. **Gap #3 (Insulin Resistance in Islet Transplant, GOLD)** — holds. No new 2025-2026 RCT; field moving to stem-cell-derived/hypoimmune islets. No completed study uses insulin-resistance metrics as a primary islet-graft outcome. Not a promotion candidate. Next audit ~2026-07-28.
4. **Gap #6 (CAR-T Access Barriers, GOLD)** — holds, evidence strengthened. New 2026 scoping review: Warnakulasuriya et al., Cancer Medicine 2026, doi:10.1002/cam4.71457 (PMC12880879), 25 studies — reaffirms racial/socioeconomic CAR-T access disparities. Diabetes-translation angle remains unaddressed by completed equity-intervention studies. Next audit ~2026-07-28.

## Credibility sweep — CLEAN
No fabricated PMIDs (>42M), no "zero SAEs/rejection", no overstated preclinical language (only matches are detector patterns inside verify_before_deploy.py).

## Pipeline rebuild — 41/41 [OK]
run_quality_improvements.py completed all 41 stages successfully.

## Blocker (requires user)
Git commit/push still blocked from sandbox: OneDrive denies unlink on .git/index.lock; every git command leaves a stale lock. Repo is many commits ahead of origin plus uncommitted changes. USER FIX (PowerShell in OneDrive copy):
    del .git\index.lock
    Get-ChildItem .git\index.* -Exclude index | Remove-Item -Force
    git add -A; git commit -m "Daily iteration 2026-06-28"; git push
Until run, today's files + state remain local-only.

## State saved
agent_state.json updated (run 75 recorded; backup agent_state.json.bak_2026-06-28). Queue reprioritized: validate_path note advanced; Gap #3/#6 next-audit dates pushed to ~2026-07-28.
